Publication & Citation Trends
Publications
39 total
Pre-clinical development of a novel CD3-CD123 bispecific T-cell engager using cross-over dual-variable domain (CODV) format for acute myeloid leukemia (AML) treatment PDF
Cited by 16
OpenAlex
Efficacy of the MDM2 Inhibitor SAR405838 in Glioblastoma Is Limited by Poor Distribution Across the Blood–Brain Barrier PDF
Cited by 40
OpenAlex
SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma PDF
Cited by 106
OpenAlex
SAR405838: An Optimized Inhibitor of MDM2–p53 Interaction That Induces Complete and Durable Tumor Regression PDF
Cited by 337
OpenAlex
Concomitant Notch activation and p53 deletion trigger epithelial-to-mesenchymal transition and metastasis in mouse gut PDF
Cited by 132
OpenAlex
Discovery of (2<i>S</i>)-8-[(3<i>R</i>)-3-Methylmorpholin-4-yl]-1-(3-methyl-2-oxobutyl)-2-(trifluoromethyl)-3,4-dihydro-2<i>H</i>-pyrimido[1,2-<i>a</i>]pyrimidin-6-one: A Novel Potent and Selective Inhibitor of Vps34 for the Treatment of Solid Tumors
Cited by 90
OpenAlex
Abstract 4648: In vitro characterization of spiro-oxindole-based modulators of the MDM2-p53 interaction and their interspecies selectivity.
Cited by 1
OpenAlex
Research Topics
Sarcoma Diagnosis and Treatment
(17)
Cancer-related Molecular Pathways
(14)
Glioma Diagnosis and Treatment
(6)
Cancer Genomics and Diagnostics
(5)
Cancer Research and Treatments
(4)
Affiliations
Centre National de la Recherche Scientifique
Université de Bordeaux
Sanofi (France)
Spanish National Cancer Research Centre
Biologie cellulaire et Cancer